azacitidine has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Huang, Z; Li, R; Li, Z; Liang, X; Lin, T; Liu, S; Ma, J; Shi, W; Tan, X; Wang, W; Ye, Z; Yu, C; Zhang, B; Zhang, H; Zhang, L; Zhang, Q; Zhao, X | 1 |
| Fujiki, K; Kano, F; Murata, M; Shiota, K | 1 |
2 other study(ies) available for azacitidine and Diabetes Mellitus
| Article | Year |
|---|---|
DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury.
Topics: Albuminuria; Animals; Azacitidine; Binding Sites; Cell Line; Cell Movement; Cell Proliferation; Cytoprotection; Decitabine; Diabetes Mellitus; Diabetic Nephropathies; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Male; Mice, Inbred C57BL; Podocytes; Promoter Regions, Genetic; RNA Interference; Sp1 Transcription Factor; Time Factors; Transcription Factor RelA; Transfection | 2017 |
Expression of the peroxisome proliferator activated receptor gamma gene is repressed by DNA methylation in visceral adipose tissue of mouse models of diabetes.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Animals; Azacitidine; Cell Proliferation; Chromatin Immunoprecipitation; Diabetes Mellitus; Dietary Fats; Disease Models, Animal; DNA Methylation; Enzyme Inhibitors; Gene Expression; Intra-Abdominal Fat; Male; Mice; Molecular Sequence Data; NIH 3T3 Cells; Obesity; PPAR gamma; Promoter Regions, Genetic; RNA, Messenger; Sequence Alignment; Sequence Analysis, DNA; Subcutaneous Fat, Abdominal | 2009 |